På grund af ertapenems begrænsede levermetabolisme, formodes det ikke at farmakokinetikken påvirkes af leverinsufficiens.
Due to the limited extent of hepatic metabolism of ertapenem, its pharmacokinetics are not expected to be affected by hepatic impairment.